March 4, 2014Open Access
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
Key Points
Key points are not available for this paper at this time.
Abstract
NCT00325195. Registered 10 May 2006, NCT01356498. Registered 27 October 2008.